Charles River Laboratories Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$1,004,852	$1,032,135	$984,168	$1,002,549
Gross Profit	338,792	357,067	317,732	284,244
EBITDA	197,767	220,892	184,226	-86,453
EBIT	112,603	101,385	63,862	-188,557
Net Income	54,422	52,326	25,469	-215,699
Net Change In Cash	1,004,852	1,032,135	984,168	1,002,549
Free Cash Flow	178,246	169,305	112,373	83,746
Cash	207,670	182,824	229,356	194,606
Basic Shares	49,426	49,316	50,853	51,138

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$4,049,989	$4,129,409	$3,976,060	$3,540,160
Gross Profit	1,331,821	1,502,556	1,462,651	1,334,638
EBITDA	581,143	1,032,118	986,148	820,160
EBIT	219,402	717,994	682,278	554,620
Net Income	10,297	474,624	486,226	390,982
Net Change In Cash	4,049,989	4,129,409	3,976,060	3,540,160
Cost of Revenue			-30,679	-4,535
Free Cash Flow	501,610	365,370	294,907	532,027
Cash	194,606	276,771	233,912	245,237
Basic Shares	51,628	51,451	51,301	51,425